As AstraZeneca’s multibillion-dollar heart drug ticagrelor (marketed as Brilinta in the U.S. and Brilique in Europe) prepares to go off-patent, a fresh investigation by The BMJ has raised troubling concerns about the integrity of the trials that supported its approval. The antiplatelet medication has been widely used for over a decade to treat patients with acute coronary syndrome, but the evidence base it rests on is now under question.

The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General. There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).

Post : Pharmacist

Deep within Assam’s vibrant ecosystem, scientists at the Institute of Advanced Study in Science & Technology (IASST), Guwahati, have uncovered a remarkable paradox: some of nature’s most toxic flora may hold potent therapeutic potential. This revelation, emerging from extensive research into poisonous plant species, could herald a paradigm shift in natural product–based medicine.